$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000150370716000125 Filed on May 13, 2016

Income Statement

Concept	2016 Q2	2016 Q1	2015 Q1
Revenue	$68.03M	$48.79M	$11.32M
YoY Change	216.12%	331.17%	154.44%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.43M	$11.82M	$1.685M
YoY Change	185.91%	601.66%	141.06%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$13.04M	$8.483M	$1.647M
YoY Change	280.18%	415.06%	169.56%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$10.44M	-$17.25M	-$1.770M
YoY Change	-49.15%	874.8%	-48.52%
Income Tax	$33.00K	$7.100M	-$300.0K
% Of Pretax Income
Net Earnings	-$27.87M	-$38.30M	-$5.014M
YoY Change	8.57%	663.8%	45.84%
Net Earnings / Revenue	-40.97%	-78.5%	-44.31%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	181.6M shares	180.7M shares	111.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q2	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$144.2M	$179.2M	$466.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$22.11M	$22.11M
YoY Change	58.74%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.563B	$2.607B	$1.124B
YoY Change	55.95%	131.85%	356.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$1.256B	$1.256B	$190.9M
YoY Change	101.09%	557.83%	183.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$343.0M	-$284.6M	-$68.64M
YoY Change	200.88%	314.69%	597.25%
Common Stock	$1.645B	$1.631B	$1.001B
YoY Change	45.87%	62.91%	433.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.302B	$1.346B	$932.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.563B	$2.607B	$1.124B
YoY Change	55.95%	131.85%	356.54%

Cashflow Statement

Concept	2016 Q2	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$27.87M	-$38.30M	-$5.014M
YoY Change	8.57%	663.8%	45.84%
Depreciation, Depletion And Amortization	$13.43M	$11.82M	$1.685M
YoY Change	185.91%	601.66%	141.06%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$10.90M
YoY Change		-100.0%	-1142.07%
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$2.265M	-$123.2M
YoY Change		-101.84%	37.57%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	181625353	shares
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2016Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	0	Employee
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	NorthStar Healthcare Income, Inc.
CY2015Q1	nshi	Accrued Costof Capital AccruedCostofCapital	770000	USD
CY2016Q1	nshi	Accrued Costof Capital AccruedCostofCapital	11000	USD
CY2016Q1	nshi	Acquisition Feeand Expense Cap AcquisitionFeeandExpenseCap	0.06
CY2015Q1	nshi	Amortizationof Feeson Investments AmortizationofFeesonInvestments	67000	USD
CY2016Q1	nshi	Amortizationof Feeson Investments AmortizationofFeesonInvestments	7000	USD
CY2015Q1	nshi	Business Acquisition Pro Forma Earnings Per Share Basicand Diluted BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted	-0.24
CY2016Q1	nshi	Business Acquisition Pro Forma Earnings Per Share Basicand Diluted BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted	-0.23
CY2016Q1	nshi	Common Stock Annualized Distribution CommonStockAnnualizedDistribution	0.675
CY2016Q1	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.00184426
CY2015Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	44261000	USD
CY2016Q1	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	39195000	USD
CY2015Q1	nshi	Distributions Payable DistributionsPayable	6380000	USD
CY2016Q1	nshi	Distributions Payable DistributionsPayable	10329000	USD
CY2015Q1	nshi	Followon Public Offering FollowonPublicOffering	700000000.0	USD
CY2015Q1	nshi	Gross Subscriptions Receivable GrossSubscriptionsReceivable	889000	USD
CY2016Q1	nshi	Gross Subscriptions Receivable GrossSubscriptionsReceivable	0	USD
CY2015Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	67000	USD
CY2016Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	521000	USD
CY2015Q1	nshi	Joint Venture Costs Incurred But Not Yet Paid JointVentureCostsIncurredButNotYetPaid	3896000	USD
CY2016Q1	nshi	Joint Venture Costs Incurred But Not Yet Paid JointVentureCostsIncurredButNotYetPaid	0	USD
CY2016Q1	nshi	Mortgage Loans On Real Estate Number Of Loans Contributing To More Than10 Percent Of Interest Income MortgageLoansOnRealEstateNumberOfLoansContributingToMoreThan10PercentOfInterestIncome	3	Investment
CY2016Q1	nshi	Mortgage Loans On Real Estate Weighted Average Period Of Contractual Maturity Including Extensions MortgageLoansOnRealEstateWeightedAveragePeriodOfContractualMaturityIncludingExtensions	P3Y10M16D
CY2015Q1	nshi	Noncashor Part Noncash Acquisition Valueof Working Capital Acquired NoncashorPartNoncashAcquisitionValueofWorkingCapitalAcquired	0	USD
CY2016Q1	nshi	Noncashor Part Noncash Acquisition Valueof Working Capital Acquired NoncashorPartNoncashAcquisitionValueofWorkingCapitalAcquired	2437000	USD
CY2015Q1	nshi	Noncashor Part Noncash Transaction Noncontrolling Interest Reallocationof Interestin Partnership NoncashorPartNoncashTransactionNoncontrollingInterestReallocationofInterestinPartnership	0	USD
CY2016Q1	nshi	Noncashor Part Noncash Transaction Noncontrolling Interest Reallocationof Interestin Partnership NoncashorPartNoncashTransactionNoncontrollingInterestReallocationofInterestinPartnership	103005000	USD
CY2016Q1	nshi	Number Of Days Past Due For Suspension Of Income Recognition NumberOfDaysPastDueForSuspensionOfIncomeRecognition	P90D
CY2016Q1	nshi	Numberof Days Past Contractual Debt Service Payments Loan Categorizedasa Weaker Credit Quality Debt Investment NumberofDaysPastContractualDebtServicePaymentsLoanCategorizedasaWeakerCreditQualityDebtInvestment	P90D
CY2016Q1	nshi	Numberof Healthcare Real Estate Properties NumberofHealthcareRealEstateProperties	15	property
CY2015Q4	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	5401000	USD
CY2016Q1	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	5401000	USD
CY2015Q1	nshi	Paymentsto Acquire Mortgage Notes Receivable Netof Fees PaymentstoAcquireMortgageNotesReceivableNetofFees	-188000	USD
CY2016Q1	nshi	Paymentsto Acquire Mortgage Notes Receivable Netof Fees PaymentstoAcquireMortgageNotesReceivableNetofFees	0	USD
CY2015Q1	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	856000	USD
CY2016Q1	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	5182000	USD
CY2016Q1	nshi	Percentof Interest Income Contributedby Investment PercentofInterestIncomeContributedbyInvestment	0.1
CY2015Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Returnof Capitalon Private Equity Fundsfor Investing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsReturnofCapitalonPrivateEquityFundsforInvestingActivities	7597000	USD
CY2016Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Returnof Capitalon Private Equity Fundsfor Investing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsReturnofCapitalonPrivateEquityFundsforInvestingActivities	5639000	USD
CY2016Q1	nshi	Share Repurchase Program Holding Period Of Shares Required For Repurchase ShareRepurchaseProgramHoldingPeriodOfSharesRequiredForRepurchase	P1Y
CY2016Q1	nshi	Stock Repurchase Program Unfulfilled Requests StockRepurchaseProgramUnfulfilledRequests	0	USD
CY2016Q1	nshi	Variable Interest Entity Number Of Entities Related To Investments And Financing VariableInterestEntityNumberOfEntitiesRelatedToInvestmentsAndFinancing	5	Investment
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	10234000	USD
CY2016Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	21942000	USD
CY2015Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	8016000	USD
CY2016Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	8681000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1614452000	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1628791000	USD
CY2015Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	2046000	USD
CY2016Q1	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3078000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29299	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33751	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	245000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	434000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5100000	USD
CY2015Q1	us-gaap	Asset Management Costs AssetManagementCosts	2714000	USD
CY2016Q1	us-gaap	Asset Management Costs AssetManagementCosts	19628000	USD
CY2015Q4	us-gaap	Assets Assets	2002228000	USD
CY2016Q1	us-gaap	Assets Assets	2606975000	USD
CY2015Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-26040000	USD
CY2016Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-41335000	USD
CY2015Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	40029000	USD
CY2016Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	68267000	USD
CY2015Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1416000	USD
CY2016Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1282000	USD
CY2015Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	USD
CY2016Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	6408000	USD
CY2015Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	58000	USD
CY2016Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	274000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	267672000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	465982000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	354229000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	179193000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	198310000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-175036000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	179137202	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	180657897	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	179137202	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	180657897	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	1791000	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	1807000	USD
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	9119000	USD
CY2016Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	13149000	USD
CY2015Q1	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	2746000	USD
CY2016Q1	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	23397000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	13085000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	72449000	USD
CY2016Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.005
CY2015Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	570985000	USD
CY2016Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1216266000	USD
CY2015Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	579750000	USD
CY2016Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1227920000	USD
CY2015Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	462000	USD
CY2016Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	444000	USD
CY2015Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-226000	USD
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7026000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7026000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2015Q4	us-gaap	Deposit Assets DepositAssets	6629000	USD
CY2016Q1	us-gaap	Deposit Assets DepositAssets	6631000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	1700000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	6800000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1685000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11823000	USD
CY2016Q1	us-gaap	Dividends Common Stock DividendsCommonStock	10273000	USD
CY2016Q1	us-gaap	Dividends Common Stock DividendsCommonStock	9633000	USD
CY2016Q1	us-gaap	Dividends Common Stock DividendsCommonStock	10329000	USD
CY2015	us-gaap	Dividends Common Stock DividendsCommonStock	88271000	USD
CY2016Q1	us-gaap	Dividends Common Stock DividendsCommonStock	30235000	USD
CY2016Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4538000	USD
CY2016Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4258000	USD
CY2016Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4612000	USD
CY2016Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13408000	USD
CY2016Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	5735000	USD
CY2016Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	5375000	USD
CY2016Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	5717000	USD
CY2016Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	16827000	USD
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10002000	USD
CY2016Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10329000	USD
CY2015Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	443000	USD
CY2016Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	30000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2015Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	92000	USD
CY2016Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2015Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	21307000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	16259000	USD
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	27325000	USD
CY2016Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	28480000	USD
CY2016Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	6408000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2877000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7836000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	22112000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	22112000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1770000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17254000	USD
CY2015Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3589000	USD
CY2016Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14037000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-345000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7091000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	836000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	114000	USD
CY2015Q1	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	2000	USD
CY2016Q1	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	51000	USD
CY2015Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	3352000	USD
CY2016Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-424000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	193000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	963000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-82000	USD
CY2015Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-137000	USD
CY2016Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-405000	USD
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1848000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	2548000	USD
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	16000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	2455000	USD
CY2015Q1	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	658000	USD
CY2016Q1	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	707000	USD
CY2015Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	43799000	USD
CY2016Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	38751000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	1647000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	8483000	USD
CY2015Q1	us-gaap	Interest Income Operating InterestIncomeOperating	3561000	USD
CY2016Q1	us-gaap	Interest Income Operating InterestIncomeOperating	5035000	USD
CY2015Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	664555000	USD
CY2016Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1377470000	USD
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	534541000	USD
CY2016Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	418296000	USD
CY2015Q4	us-gaap	Land Land	140734000	USD
CY2016Q1	us-gaap	Land Land	318901000	USD
CY2015Q4	us-gaap	Land Improvements LandImprovements	8384000	USD
CY2016Q1	us-gaap	Land Improvements LandImprovements	8407000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	596728000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	1255588000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2002228000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2606975000	USD
CY2016Q1	us-gaap	Long Term Debt LongTermDebt	1227920000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1136540000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	22378000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	44347000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	20948000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3516000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	191000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	5356000	USD
CY2016Q1	us-gaap	Minority Interest MinorityInterest	5420000	USD
CY2016Q1	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9999
CY2015Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	192934000	USD
CY2016Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	192987000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	207352000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-18219000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13034000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-141797000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3992000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15020000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-85000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5013000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38297000	USD
CY2015Q1	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2016Q1	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	648211000	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	4472000	USD
CY2016Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	149000	USD
CY2015Q4	us-gaap	Notes Payable NotesPayable	570985000	USD
CY2016Q1	us-gaap	Notes Payable NotesPayable	1216266000	USD
CY2016Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2015Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	7754000	USD
CY2016Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	43476000	USD
CY2015Q4	us-gaap	Other Assets OtherAssets	20382000	USD
CY2016Q1	us-gaap	Other Assets OtherAssets	15369000	USD
CY2015Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	536000	USD
CY2016Q1	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	1170000	USD
CY2015Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2016Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2015Q4	us-gaap	Other Liabilities OtherLiabilities	3018000	USD
CY2016Q1	us-gaap	Other Liabilities OtherLiabilities	3943000	USD
CY2015Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	0	USD
CY2016Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	276000	USD
CY2015Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	10900000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2015Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	736000	USD
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2703000	USD
CY2015Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	16580000	USD
CY2016Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	29908000	USD
CY2015Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2325000	USD
CY2016Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3322000	USD
CY2015Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	1130000	USD
CY2016Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	139618000	USD
CY2015Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	9781000	USD
CY2016Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	28000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-5014000	USD
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	790000	USD
CY2016Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2167000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1100000000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	123976000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	438000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	9258000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	16705000	USD
CY2015Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2000	USD
CY2016Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	149000	USD
CY2015Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	93750000	USD
CY2016Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2015Q1	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	7000	USD
CY2016Q1	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	463000	USD
CY2015Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	0	USD
CY2016Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	-60000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-82744000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-38382000	USD
CY2015Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	19386000	USD
CY2016Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	26143000	USD
CY2015Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	851639000	USD
CY2016Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1747929000	USD
CY2015Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	832253000	USD
CY2016Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1721786000	USD
CY2015Q4	us-gaap	Real Estate Investments RealEstateInvestments	832253000	USD
CY2016Q1	us-gaap	Real Estate Investments RealEstateInvestments	1721786000	USD
CY2015Q1	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	3906000	USD
CY2016Q1	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	18435000	USD
CY2015Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2016Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	41000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	15612000	USD
CY2016Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	31468000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-216099000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-284631000	USD
CY2015Q1	us-gaap	Revenues Revenues	11315000	USD
CY2016Q1	us-gaap	Revenues Revenues	48787000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	29000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	34000	USD
CY2015	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	46380000	USD
CY2016Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	16705000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	697491000	USD
CY2016Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	319000	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	115000	USD
CY2016Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	34000	USD
CY2015	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	3928000	USD
CY2016Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	2703000	USD
CY2015	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	406544	shares
CY2016Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	284121	shares
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3900000	USD
CY2016Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2700000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	1400144000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	1345967000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	831985000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1405500000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1351387000	USD
CY2015Q4	us-gaap	Tenant Improvements TenantImprovements	1522000	USD
CY2016Q1	us-gaap	Tenant Improvements TenantImprovements	1522000	USD
CY2015Q1	us-gaap	Tenant Reimbursements TenantReimbursements	3848000	USD
CY2016Q1	us-gaap	Tenant Reimbursements TenantReimbursements	25041000	USD
CY2015	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	9.66
CY2016Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	9.51
CY2016Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7000000	USD
CY2016Q1	us-gaap	Variable Interest Entity Nonconsolidated Carrying Amount Assets And Liabilities Net VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesNet	418300000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	109371002	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	180150495	shares
CY2016Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business and Organization</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NorthStar Healthcare Income, Inc. (the “Company”) was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity senior housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living (“ILF”) facilities and continuing care retirement communities (“CCRC”), which may have independent living, assisted living, skilled nursing and memory care available on one campus. The Company also invests in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary services businesses. The Company’s investments are predominantly in the United States, but it also selectively makes international investments. The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company conducts its operations so as to continue to qualify as a REIT for U.S. federal income tax purposes.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s equity investments are generally healthcare properties, which are either structured as net leases to healthcare operators or operated through management agreements with independent third-party operators, where applicable through the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”) structures that permit the Company, through taxable REIT subsidiaries (“TRS”), to have direct exposure to resident fee income and incur related operating expenses. The Company’s debt investments consist of first mortgage loans and mezzanine loans. The Company currently owns no securities investments.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is externally managed and has </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> employees. Prior to June 30, 2014, the Company was managed by an affiliate of NorthStar Realty Finance Corp. (NYSE: NRF) (“NorthStar Realty”). Effective June 30, 2014, NorthStar Realty spun-off its asset management business into a separate publicly traded company, NorthStar Asset Management Group Inc. (NYSE: NSAM) (the “Sponsor”). The Sponsor and its affiliates provide asset management and other services to the Company, NorthStar Realty, NorthStar Realty Europe Corp. (NYSE: NRE), other sponsored public retail-focused companies and any other companies the Sponsor and its affiliates may manage in the future (collectively, the “NSAM Managed Companies”), both in the United States and internationally. Concurrent with the spin-off, affiliates of the Sponsor entered into a new advisory agreement with the Company and each of the other NSAM Managed Companies. Pursuant to the Company’s advisory agreement, NSAM J-NSHC Ltd, an affiliate of the Sponsor (the “Advisor”), agreed to manage the day-to-day operations of the Company on terms substantially similar to those set forth in the Company’s prior advisory agreement with NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”). References to the “Prior Advisor” herein refer to the services performed by and fees paid and accrued to the Prior Advisor during the period prior to June 30, 2014. The spin-off of NorthStar Realty’s asset management business had no impact on the Company’s operations.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Substantially all the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are the Prior Advisor and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Sponsor. The Prior Advisor invested </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the Operating Partnership in exchange for common units and the Special Unit Holder invested </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. As the Company issues shares, it contributes substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company’s limited partnership interest in the Operating Partnership was </font><font style="font-family:inherit;font-size:10pt;">99.99%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s charter authorizes the issuance of up to </font><font style="font-family:inherit;font-size:10pt;">400.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock with a par value of </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share and up to </font><font style="font-family:inherit;font-size:10pt;">50.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of preferred stock with a par value of </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company initially registered to offer up to </font><font style="font-family:inherit;font-size:10pt;">100.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares pursuant to its primary offering to the public (the “Initial Primary Offering”) and up to </font><font style="font-family:inherit;font-size:10pt;">10.5 million</font><font style="font-family:inherit;font-size:10pt;"> shares pursuant to its distribution reinvestment plan (the “Initial DRP”), which are herein collectively referred to as the Initial Offering. The Initial Offering (including </font><font style="font-family:inherit;font-size:10pt;">8.6 million</font><font style="font-family:inherit;font-size:10pt;"> shares reallocated from the Initial DRP) was completed on </font><font style="font-family:inherit;font-size:10pt;">February 2, 2015</font><font style="font-family:inherit;font-size:10pt;"> by raising </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;">. All of the shares initially registered for the Initial Offering were issued.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">February 6, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company’s registration statement on Form S-11 was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) for a follow-on public offering (the “Follow-on Offering”) of up to </font><font style="font-family:inherit;font-size:10pt;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;"> which includes up to </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;"> in shares pursuant to its follow-on primary offering (the “Follow-on Primary Offering”) and up to </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> in shares pursuant to its follow-on distribution reinvestment plan (the “Follow-on DRP”). The Company stopped accepting subscriptions for the Follow-on Offering on December 17, 2015 and all of the shares initially registered (including </font><font style="font-family:inherit;font-size:10pt;">$159.5 million</font><font style="font-family:inherit;font-size:10pt;"> of shares reallocated from the Follow-on DRP) for the Offering were issued on or before January 19, 2016. The Company registered an additional </font><font style="font-family:inherit;font-size:10pt;">30.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares to be offered pursuant to DRP beyond the completion of the Offering and continues to offer such shares.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Initial Primary Offering and the Follow-on Primary Offering are collectively referred to as the Primary Offering and the distribution reinvestment plan, including but not limited to, the Initial DRP and Follow-on DRP, are collectively referred to as the DRP. Additionally, the Primary Offering and the Initial DRP and Follow-on DRP are collectively referred to as the Offering.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company retained NorthStar Securities, LLC (the “Dealer Manager”), formerly a subsidiary of NorthStar Realty that became a subsidiary of the Sponsor upon completion of the spin-off, to serve as the dealer manager for the Primary Offering. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From inception through </font><font style="font-family:inherit;font-size:10pt;">May 6, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company raised total gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$1.8 billion</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions.</font></div></div>

Files In Submission

Name	View Source	Status
0001503707-16-000125-index-headers.html	Edgar Link	pending
0001503707-16-000125-index.html	Edgar Link	pending
0001503707-16-000125.txt	Edgar Link	pending
0001503707-16-000125-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nshi-0331201610xq.htm	Edgar Link	pending
nshi-20160331.xml	Edgar Link	completed
nshi-20160331.xsd	Edgar Link	pending
nshi-20160331_cal.xml	Edgar Link	unprocessable
nshi-20160331_def.xml	Edgar Link	unprocessable
nshi-20160331_lab.xml	Edgar Link	unprocessable
nshi-20160331_pre.xml	Edgar Link	unprocessable
nshiexhibit311-03312016.htm	Edgar Link	pending
nshiexhibit312-03312016.htm	Edgar Link	pending
nshiexhibit321-03312016.htm	Edgar Link	pending
nshiexhibit322-03312016.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
redloca10.jpg	Edgar Link	pending
redtypea05.jpg	Edgar Link	pending
redtypeno2.jpg	Edgar Link	pending
reloca14.jpg	Edgar Link	pending
report.css	Edgar Link	pending
retypea21.jpg	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2016 Q2 Form 10-Q Financial Statement

#000150370716000125 Filed on May 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2016 Q2 Form 10-Q Financial Statement

#000150370716000125 Filed on May 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs